About New Science Ventures
Investments are channeled by New Science Ventures into early, mid, and late-stage companies operating in pharmaceuticals, biologics, medical devices, cellular infrastructure, and sensor networks. Geographic focus is placed on the US, Europe, India, and China. Portfolio holdings include Ferric, Caringo, Ovizio, and Kateeva. Operations are headquartered in New York, United States, with emphasis on venture capital funding for innovative technologies.
- Headquarter New York, United States
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of New Science Ventures
Unlock access to complete
Partner Team
4 people
Controller Team
1 people
Managing Team
1 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of New Science Ventures
Detailed funding history for New Science Ventures
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by New Science Ventures
Investment portfolio details for New Science Ventures
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - New Science Ventures
Detailed financials for New Science Ventures
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
New Science Ventures Comparisons
Peer comparison for New Science Ventures
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of New Science Ventures
Detailed competitors of New Science Ventures
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on New Science Ventures
Complete news archive for New Science Ventures
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about New Science Ventures
New Science Ventures is headquartered in New York, United States. It is registered at New York, New York, United States.
Investments are channeled by New Science Ventures into early, mid, and late-stage companies operating in pharmaceuticals, biologics, medical devices, cellular infrastructure, and sensor networks. Geographic focus is placed on the US, Europe, India, and China. Portfolio holdings include Ferric, Caringo, Ovizio, and Kateeva. Operations are headquartered in New York, United States, with emphasis on venture capital funding for innovative technologies.